Archive · 10 Aug 2026
Broker Maintains Buy on Godrej Consumer with ₹1,250 Target
Godrej Consumer Products is a company that makes home care and personal care products.
A person who studies companies wrote a report to help people decide what to do with their money.
The report says the company is doing its job well and growing nicely.
It tells people they should keep buying the company's shares, which is called a 'Buy' rating.
The expert thinks the shares will be worth about ₹1,250 by June 2027.
Right now, the shares cost about ₹1,035.60.
The company shared its latest results, and its sales grew by 19 percent.
It also earned more profit than before.
However, the company buys some materials from other countries, and those can cost more, so managing costs will stay tricky.
A brokerage maintained its Buy rating on Godrej Consumer Products (GCPL) with a June-2027 target price of ₹1,250, based on 44x P/E.
The target price compares with a current market price of ₹1,035.60.
Q1 results were in line with estimates, with 19% topline growth, 15% EBITDA growth and 10% earnings growth.
Volume growth reached 9% in Q1, and revenue growth was broad-based at 11-12% across home care and personal care after the exports business was reallocated.
Management reiterated its FY27 guidance but flagged sustained raw material headwinds from high dependence on imports.
- Who
- Godrej Consumer Products (GCPL), the consumer goods company whose Q1 results were assessed by a brokerage maintaining a Buy call.
- What
- The brokerage kept a Buy rating with a June-2027 target price of ₹1,250, based on 44x P/E, after Q1 delivered 19% topline, 15% EBITDA and 10% earnings growth.
- When
- Q1 results and the broker's note, published on August 10, 2026; the target price applies to June 2027.
- Where
- India, where GCPL's home care and personal care segments grew 11-12%; the company also cited its GAUM business.
- Why
- Strong execution and healthy revenue momentum that can absorb category disruptions, despite raw material headwinds from import dependence.
- Broker Rating
- Buy
- Target Price (Jun-27)
- ₹1,250
- Current Market Price
- ₹1,035.60
- Valuation
- 44x P/E (5-year average forward P/E)
- Q1 Revenue Growth
- 19%
- Q1 EBITDA Growth
- 15%
- Q1 Earnings Growth
- 10%
- Q1 Volume Growth
- 9%